Biodesix Adds $8.8M in Financing
Biodesix Inc., a molecular diagnostics company, has added $8.8 million in a follow-on sale of its Series D preferred shares. The money came from existing investors, Biodesix said. Specifics were not released.
12 April 2013•2 mins read
